phd in cancer research in india

Cancer Biology Department was established in 1980 with primary research focus area on Cell Biology, Molecular Endocrinology and Biochemistry which has now metamorphosed into 6 state of the art research laboratories as under:

The Department is involved in translational cancer research in and caters advanced diagnostic services for cancer patients. The department offers MSc in Cancer Biology and PhD in Life Sciences in affiliation with Gujarat University and imparting quality education with active cancer research. It also runs GSBTM sponsored Cancer Biology Finishing School. Microarray, Next Generation sequencing, ddPCR and BSL II Culture facility is established for the translational cancer research.

• Shoolini Online
• Distance Education
• SU Students
• Online Payment

+1 (396) 486 4709

Biotechnology

PhD Cancer Biology

Eligibility:

• Duration: 3 Years
• Admission Criteria:

Eligibility :

• Duration : 3 Years
• Admission Criteria :

PhD Cancer Biology at Shoolini University focuses on hi-impact cutting-edge research and learning to provide solutions to one of the biggest health concerns for humankind.   

This interdisciplinary program opens new avenues for students as per the rising demand of trained Cancer Biologists in the academic and corporate world.   

For substantial contribution, Shoolini University has established a Cancer Research Centre on the campus. Equipped with state-of-the-art technology to utilise the medicinal wealth of the Himalayas to treat cancer, this facility houses five different research groups actively engaged in research on various aspects of cancer biology, like herbal cancer therapy, cancer immunotherapy, drug delivery and chemical biology group. The goal of this top-notch, innovative, and pioneering research centre is to develop better formulations to control different forms of cancer through innovative cancer therapies.

• Rising H index and ranked #1 in Citation in Asia as per QS Ranking.  
• State-of-the-art infrastructure with 104+ labs 
• Faculty from Oxford, National Cancer Institute (USA), NIH (USA), IISc & Oxford  
• Students file patents with faculty members 
• Students receive JRF at UG & PG levels 

Summit Research

India’s first undergrad research program where students can be research fellows.

One-Student One-Patent

Students are mentored to file patents in the first year itself.

Well-Equipped Laboratories

Commercial Food Testing Lab sponsored by the Ministry of Food Processing Industries (GoI)

PhD Cancer Biology Career Opportunities

Program Details

Top faculty.

Rohit Sharma

Assistant Professor

Paromik Bhattacharyya

Vandana Guleria

Sourabh Kulshrestha

Alumni Jamia Millia Islamia, University of Kentucky, USA & Max-Planck Institute, Germany

Professor, PhD (AMU), Post Doc. University of Houston, USA & Auburn University, USA

Lokender Kumar

Alumnus (Colorado School of Mines, USA, Panjab University, HPU), Fellowships (DST-Inspire & CSIR-UGC Junior Research) Has a Publication in Nature Journal

Nitika Thakur

Alumna (Shoolini University), ARS-NET 2016, Awards (Humboldt University, Berlin-- Best Presentation)

Jyoti Mehta

PhD in Microbiology (Shoolini University)

Gaurav Saxena

Alumnus (PhD--B B Ambedkar Central University, Lucknow), Awards (Young Environmentalist Award - 2018, Young Achiever Award - 2019, Young Scientist Award - 2021) Active Member (AMI, ISCA, MicroSoc)

Student Voices

Top campus recruiters.

Some of the major companies that visit our campus and hire our graduates are:

Frequently Asked Questions

Latest blogs.

Explore the latest insights and updates in our newest Shoolini University blogs!

Still have Queries? Contact Us

Please fill in the form and an expert from the admissions office will call you in the next 4 working hours.

• From the Director
• Vision and Mission
• The Council
• Board of Trustees
• Finance Committee
• Deans of Administration
• Deans of Faculties
• Deans of Divisions
• Financial Controller
• Vigilance Officers
• Administrative Officers
• Administrative Centres
• Finance & Accounts
• JRD Tata Memorial Library
• Tackling Climate Change – 36% reduction of emissions by 2025
• Jaya-Jayant Award
• Alumni Award
• Prof. Rustom Choksi Award
• Amulya and Vimala Reddy Lecture Award
• Prof. Priti Shankar Teaching Award
• IISc Distinguished Alumnus/alumna Award
• Prof. S. K. Chatterjee Award for Outstanding Woman Researcher or Industry Leader
• Memorial Lectures
• Golden Jubilee Memorial Lectures
• Endowment Lectures
• Centenary Lectures
• Special Lectures / Institute Lectures
• The Cell Press – TNQ India -IISc Distinguished Lectureship Series
• Endowed Visiting Chair
• Endowed chairs for the Faculty
• Young Investigators
• Scheme, Regulations, Bye-laws
• Plan a visit to IISc
• Getting around Campus
• Telephone Directory
• Holidays -2024
• Medium of instruction in IISc
• Status of IISc
• CGPA to Percentage Conversion
• Migration Certificate / TC
• R​elabelling of MSc(Engg)
• Campus Life
• My Life@IISc: a student perspective
• Hostels/Mess
• Official transcripts
• Campus Facilities
• Health Centre
• Auditoria and Seminar Halls
• Internal Committee Against Sexual Harassment (ICASH)
• Complaints related to caste-based discrimination
• Fee Structure
• IISc A/c for Tuition Fee
• Students Affairs Committee
• Ombudsperson
• Online Ph D thesis processing with ScholarOne
• Useful Forms
• Academic Integrity
• Students Council
• PG students’ information handbook 2024
• PG students’ information handbook 2023
• PG Students’ Scheme of Instruction
• UG Students’ Handbook & SOI
• Office of Laboratory Safety and Environmental Health
• Student Code of Conduct – 2019
• Opportunities for Current Students
• Apply to IISc
• Announcements
• Campus Placement
• Student Achievements
• Faculty Information Handbook
• Tenure-track Assessment
• Faculty Association
• Faculty Club
• Funding Agencies
• Funding Opportunities
• Institute Support for Travel
• Legal Agreements
• Request for Tenders
• Apply for Faculty Positions
• Satish Dhawan Visiting Professor/Scientist
• Honorary Fellows
• Retired Faculty
• Apply for Postdocs
• Post Doctoral Researchers
• Project Associates
• campus facilities
• Retired Staff
• Main Guest House, IISc
• Centenary Visitors’ House, IISc
• Hoysala Guest House
• Jawahar Visitors’ House
• Division of Biological Sciences
• Division of Chemical Sciences
• Division of Electrical, Electronics, and Computer Sciences (EECS)
• Division of Interdisciplinary Sciences
• Division of Mechanical Sciences
• Division of Physical and Mathematical Sciences
• Centres under the Director
• Autonomous Societies / Centres / Section 8 Companies
• Departments
• Faculty Positions
• Four Year Bachelor of Science(Research)
• B.Tech in Mathematics and Computing:
• Continuing Education
• UGC Video links
• Student Information Handbook 2023
• Graduate Programmes
• Online Applications
• Contact – Admissions Unit
• Contact – Departments
• Research Highlights
• Featured Research
• Institute Colloquia
• Thematic Research Clusters
• Research Publications
• Patenting at IISc
• Press Releases
• Achievements
• IISc in the news
• Positions open
• Research Collaboration
• Industrial Consultancy and Research
• Technology Transfer
• Giving to IISc
• Enterpreneurship
• Positions Open
• Accr. & Ranking

Breast Cancer and Stem Cells

Cancer stem cells (CSCs) are a subpopulation of cancer cells endowed with stem cell properties and are proposed to be major drivers of tumor initiation and progression. Furthermore, being resistant to conventional therapies, the CSCs are predicted to be main culprits leading to tumor relapse. The primary focus of Dr. Rangarajan’s laboratory is to understand the origin and biology of CSCs, and to develop strategies to target them towards more effective cancer treatment.

The “stem cell theory” of cancer predicts that cancers originate in the normal, adult stem cells. To test this, Dr. Rangarajan’s group introduced various oncogenes into stem/progenitor cells of normal breast tissue cultured as floating ‘mammospheres’. A specific “oncogene combination” converted these cells into tumorigenic cells. Interestingly, a significant sub-population of these transformed cells harbored CSCs that initiated new tumors in test animals. Furthermore, gene expression analyses revealed striking similarities between the mammosphere-derived tumors generated within laboratory mice and naturally-arising breast adenocarcinomas encountered in the clinic.  This lent early evidence to the provocative notion that solid tumors may originate in adult stem cells. Further, this laboratory-generated breast “cancer stem cell line” also offers a unique system for deciphering the mechanisms of self-renewal in CSCs, and drug-screening.

Dr. Rangarajan ’s contribution to the emerging field of ‘cancer stem cell biology’ earned her the National (Junior) Women Bioscientist Award by the Department of Biotechnology, Govt. of India.

Cancer Immunology and Immunotherapy

  Apply Now  

The PhD Program in Cancer Immunology and Immunotherapy at Moffitt provides an enriched educational environment by blending advanced studies in fundamental cancer immunology and novel immunotherapies. The program fosters interdisciplinary research through collaborations with experts in immunology, oncology, molecular biology, metabolism, bioengineering, bioinformatics and translational medicine.

Moffitt Cancer Center is a designated Comprehensive Cancer Center by the National Cancer Institute (NCI), signifying the highest level of recognition in cancer research and treatment. This designation underscores Moffitt's excellence in various aspects such as fundamental and clinical research, prevention, education, outreach and patient care.

For more information, contact the Program Coordinator at [email protected] .

Cancer Immunology and Immunotherapy PhD

• About the Program
• Meet our Students
• Facilities and Cores
• Funding Support
• About Tampa
• Back to Cancer Immunology and Immunotherapy PhD

Cambiar el idioma

Si no encuentra la información que busca o si desea programar una cita, llámenos gratis al 1-888-663-3488 .

An official website of the United States government

The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

• Publications
• Account settings

Preview improvements coming to the PMC website in October 2024. Learn More or Try it out now .

• Advanced Search
• Journal List
• Indian J Med Res
• v.148(4); 2018 Oct

Cancer research in India: Challenges & opportunities

Mayank singh.

Department of Medical Oncology, Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi 110 029, India

Chandra Prakash Prasad

Thoudam debraj singh, lalit kumar.

With changing lifestyle, improved longevity and better control of infectious diseases, non-communicable diseases have emerged as major health problems worldwide, more so in developing countries. After cardiac diseases, cancer has emerged as an important cause of morbidity and mortality in India. According to The National Centre for Disease Informatics and Research of the Indian Council of Medical Research (ICMR) at Bengaluru, India, 1.45 million cases of cancer were estimated to be diagnosed in 2016. This burden is likely to become double in the next 20 years 1 , 2 .

Magnitude & pattern of various cancers in India

The National Cancer Registry Programme was commenced by the ICMR in December 1981 and is a major source of information on cancer incidence and pattern in the country. Currently, there are 29 population-based cancer registries (PBCRs) and 29 hospital-based cancer registries. These cover about 10 per cent of India's population. Of these, 11 PBCRs are located in the North-East (NE) region. Age-adjusted incidence (per 100,000) rate for males is higher in the West - 631.9 in Brazil, 493.9 in USA - Michigan, compared to India 270.0 in Aizawl district and 149.4 in Delhi. Corresponding figures in females are 474.6 in Brazil, 363.3 in USA, 207.7 in Aizawl and 144.8 in Delhi (India) per 100,000, respectively 3 . The top five cancers among men are lung, head and neck region (mouth, tongue and larynx), prostate and oesophagus. While among women - breast, cervix, ovary, oral cavity and uterine cancer are most common 3 . The incidence of cervical cancer is declining over the past three decades in Delhi, Chennai, Bengaluru, Bhopal, Mumbai and Barshi PBCRs. The incidence of colon/rectum, lung, breast and prostate cancer is gradually rising in these registries 3 .

There is significant geographical variation in the incidence of cancer in India. For example, in the NE region, the incidence of cancer is highest in India, for both sexes. In males, Aizawal district (located in Mizoram) reported highest cases while Papumpare district in Arunachal Pradesh had the highest number in females. Higher incidence of gallbladder cancer in north India and NE region compared to other parts, higher incidence of stomach cancer in Chennai and Bengaluru PBCRs, oesophagus cancer in Kashmir and NE region would indicate different aetiological factors operating, for example, environmental, diet, lifestyle and genetic factors 4 . Nearly 50 per cent of cancers in males and 15 per cent in females are related to the use of tobacco in different forms. These include cancers of aerodigestive tract (head and neck, lung and oesophagus), pancreas and renal and urinary bladder 4 . It is clear that the biggest measure to reduce the incidence of these cancers would be to reduce the consumption of tobacco. Specific cancer research programmes to focus on biology of population present in various States with PBCRs will help determine risk factors responsible and suggest strategies for prevention.

Delay in diagnosis

Almost 75-80 per cent of patients have advanced disease (Stage 3-4) at the time of diagnosis 5 . This has been attributed to the late presentation which in turn is due to low level of awareness in the population and among community physicians, lack of screening programmes, lack of diagnostic facilities locally and vast distances to travel to reach a major tertiary cancer centre, financial constraints and stigma associated with the diagnosis. The situation is even worse in rural areas (69% of total population) where patients and families have to travel a long distance to reach a tertiary care oncology centre. Lack of place to stay, long time taken for investigations, limited finances, language and cultural differences are also some of the limitations 4 . As per data from rural-based PBCRs, the incidence of cancer is low in rural India compared to urban PBCRs 2 . Even the pattern of cancers in rural PBCRs is different compared to those in urban PBCRs, suggesting a different policy/approach to adopt in rural areas.

Infrastructure

One of the major reasons for not being able to implement screening programme in India has been lack of workforce - physicians, health workers, technical staff and pathologist to review pathological material. The preference of healthcare personnel to work in urban settings has also resulted in unequal distribution of healthcare centres and practitioners. Many tertiary care centres (not all) have a comprehensive team of professionals comprising medical, radiation and surgical oncologists, pain and palliative care experts and auxiliary services, for example, diagnostics and pathological tests. A complex team like this is yet to be a reality in rural India 6 .

Available data from randomized trials done in south India suggest that simple innovative methods such as visual inspection-based screening (for oral cavity) 7 , visual inspection with acetic acid application for cervical cancer 8 may be useful and cost-effective methods of screening for these two common cancers. Similarly, for breast cancer self-examination or examination by a physician may be alternative methods to screening mammography 9 which are doable for early detection of breast cancer, as detection in early stages is amenable for treatment with curative option with less morbidity. Ultimately, the screening programmes can bring down the incidence of some of the common cancers in India. There has been effort by the Government of India (GOI) to establish regional cancer centres in rural areas, and upgrade medical colleges with oncology department. Under the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Disease and Stroke, the GOI has allocated ₹ 120 crores each for the establishment of 20 State-level cancer centres 10 . The GOI has also allocated 20 million USD to develop 23 new tertiary care centres and to strengthen 27 regional cancer centres 10 . Under the ‘ Pradhan Mantri Swasthya Yojna ’, eight new cancer centres would be set up in various parts of country and 58 existing medical colleges would be upgraded in a phased manner. This is a mammoth task and will take some years before this translates into standard care and survival benefit. One solution to this problem might be setting up and improving primary care services in rural areas and educating people about cancer, environmental pollution, clean drinking water, healthy diet and avoid tobacco use 11 . Experienced health practitioner, researchers and physicians should concentrate on early detection of cancer, as cure rates are high, if cancer is detected in early stage.

Several non-government organizations are engaged in increasing public awareness, supporting screening, early detection, patient and family support services and palliative care by providing home care 4 , 12 . There is a need to consolidate and strengthen their role in national cancer control programme. Further, the ICMR has taken initiative to publish consensus documents on common cancers in India to improve quality and standardized cancer care. These are expert and evidence-based guidelines to promote uniformity and to ensure the quality of treatment across cancer centres in India 13 . In recent years, the government has tried to address these issues by establishment of the National Health Mission and insurance schemes such as Rashtriya Swasthya Bima Yojna (a central government initiative); Rajiv Aarogyasri Scheme (an Andhra Pradesh government initiative); Vajpayee Arogyashree Scheme (a Karnataka government initiative) 12 , and also Gujarat health scheme model 13 . The emphasis is now to educate people about these programmes.

Clinical research

Although a notable progress in this field has been made in the recent years, there is a need to develop proper clinical research environment. This includes exposing graduate and postgraduate medical students, community physicians and medical college teachers about translation clinical research, and developing adequate infrastructure. Indian pharmaceutical industry has made phenomenal growth in the field of generic molecules; they need to invest in the development of new molecules and India centric cancer research 14 , 15 .

India has a large pool of individuals with genetic diversity (4000 anthropologically distinct groups and 22 languages) 14 . This provides an opportunity to study environmental influences on drug metabolism (such as smoking, alcohol and use of herbal medicine), variation in drug targets (for example, higher incidence of activating mutations of epidermal growth factor receptor in lung cancer in patients from Asia), and genetic polymorphism in drug-related genes. Indian population is unique in terms of genetics, culture, languages and food habits. Well-planned genome-wide association studies may yield insights into disease aetiology and potential responses to therapy 14 . In the era of precision medicine, it will be important to define risks or susceptibility of certain population or ethnic subgroups for high incidence of cancer seen in these areas 16 and also from treatment point of view if these subgroups need dose modification or special precaution during the treatment. Translational studies involving imaging, pathology, gene expression profiling, sequencing, bioinformatics and detection of circulating tumour cells can be done in few centres, and then data generated can be evaluated for its translation at other centres 14 , 15 .

Key priority areas for research

One of the important tasks would be to develop consensus on key priorities for cancer research in Indian context based on common cancers in males and females in a particular region. There is a need to focus research on prevention of some cancers with high incidence in certain areas, for example, gallbladder cancer in Gangetic belt, penile cancer in rural population, oesophageal cancer in NE region, colon cancer in Goa, stomach cancer in southern and northeast India 4 . Whether these regional differences in epidemiology are due to a difference in genomics and biology or due to differences in the prevalence of cancer risk factors or both are not yet known and would be an important area of research 14 . These cancers are rare in West and therefore, not a focus for large research programmes. Similarly, directing research for upcoming problems like lifestyle and obesity-related cancers would be timely.

Since most patients have advanced disease and poor performance status at presentation, research efforts to develop cost-effective protocols for palliative care would be meaningful. Developing protocols to less toxic regimens ( e.g . metronomic therapy with minimal visits to a busy cancer centre) 17 and minimizing need for imaging ( e.g . computed tomography scan) 18 in the follow up would be simple, yet important solutions. An active collaboration between investigators, funding agencies, industry and regulatory bodies would be important to understand needs of each other.

Way forward

Cancer in India is emerging as a major cause of morbidity and mortality. Some of the key features include young age (generally one decade younger compared to the western population), advanced disease, poor performance status and possibly more aggressive phenotype. While many tertiary cancer centres have state of the art diagnostic workup and treatment protocols, this is yet to reach to a standard level in many other regional cancer centres and hospital in smaller towns. Focussing on epidemiological research, screening for certain cancers and clinical trials India-centric common cancers may provide solutions for improvement in outcome. A planned and teamwork approach at the institution level and collaboration with different research teams are likely the key to success.

Conflicts of Interest : None.

: Health Promotion Clinic, Mon-Fri, Time: 9:30AM - 4PM | Contact: 0120–2446938

ICMR – National Institute of Cancer Prevention and Research

Ministry of Health and Family Welfare, Government of India

Notification |

Conflict of interest-declaration click here | results for the post of technical officer-b (bio informatics) interview held on 29.02.2024 –  download result | results of the interview for the post of tob-(it/cs) held on 19.03.2024 –  download result | list of the candidates shortlisted for phd interviews (faculty of medical research, acsir) august 2024 session at icmr-nicpr, noida download here | notice : provisional 3rd list of candidates shortlisted/waitlisted for selection to the post of technical assistant, technician-1 and lab attendant - download notice | notice for document verification for provisionally waitlisted candidates for the following posts will be held on 16.04.2024 from 10.00 am to 04.00 pm. candidates can come for document verifications on 16.04.2024. - download notice | call for summer training & dissertation program 2024 - download flyer    | registration  |  document verification notice for the permanent post of technical assistant it/cs - download notice    | result for the post of technical assistant(it/cs) exam held on 22.02.2024 - download notice    |   notice for shortlisted candidates for interview for the post of tob-(it/cs) - download notice    |  phd admissions, august 2024 admission notice , director desk, national institute of cancer prevention and research has a unique approach of amalgamating strong basic, clinical, and applied research, involving medical and community practice with an emphasis on early detection, primary and secondary prevention of cancer. the thrust areas of research include the cancer of the uterine cervix, breast and oral cavity. , departments & faculty, division of preventive oncology & population health, division of clinical oncology, division of molecular biology, division of epidemiology & biostatistics, division of bioinformatics, division of cytopathology, flagship projects, career opportunity, publications, list of published articles, annual report, academic activities, academic events photos, academic news bulletin videos, about nicpr, icmr timelines , health promotion, diagnostic facilities, tobacco cessation , library/computation and lan, तीसरे चरण का सीरो सर्वे खत्म अब रिपोर्ट आने का इंतजार | डॉ. शालिनी सिंह, smokeless tobacco cessation course, smokeless tobacco use and vaping, डॉ. शालिनी सिंह , निदेशक icmr-nicpr ने कोरोना योद्धाओ पर चल रहे मानसिक संतुलन अध्ययन के बारे में विचार व्यक्त किए |, health promotion clinic, who fctc knowledge hub on smokeless tobacco, विश्व तम्बाकू निषेद्य दिवस ३१ मई २०२२ को जांच शिविर में बस डिपो के बस चालक व परिचालकों को उनकी जांच के साथ साथ तम्बाकू छुड़वाने की सलाह व तम्बाकू सेवन से होने वाले दुष्प्रभावों के बारे में जानकारी दी गयी.

विश्व तम्बाकू निषेद्य दिवस ३१ मई २०२� ...

मातृ भाषा हिंदी के अधिकाधिक प्रयोग व प्रचार-प्रसार हेतु हिंदी प्रशिक्षण कार्यशाला का आयोजन 04/03/2022 को संस्थान में आयोजित किया गया

मातृ भाषा हिंदी के अधिकाधिक प्रयोग व � ...

Cancer Awareness Program on 7.2.2022 at NICPR for maintenance staff of our institute

Cancer Awareness Program on 7.2.2022 at NICPR for maintenance staff of our institute ...

सतर्कता जागरूकता सप्ताह 30 अक्टूबर – 05 नवंबर 2023

आज़ादी के अमृत महोत्सव का संकल्प और कैंसर मुक्त भारत का आव्हान स्वतंत्रता दिवस की 77 वीं वर्षगांठ हर्षोल्लास से मना रहा राष्ट्रीय कैंसर रोकथाम एवं अनुसंधान संस्थान.

आज़ादी के अमृत महोत्सव का संकल्प और कैंसर मुक्� ...

हिंदी भाषा के प्रचार, प्रसार एवं कार्यालय के सभी कर्मचारियों में हिंदी में कार्य करने और उत्साह बढ़ाने हेतु हिंदी पखवाड़ा समारोह 1 से 15 सितम्बर 2022 को आयोजित किया गया

हिंदी भाषा के प्रचार, प्रसार एवं कार्यालय के स ...

सतर्कता जागरूकता सप्ताह 31 अक्टूबर – 06 नवंबर 2022 

सतर्कता जागरूकता सप्ताह 31 अक्टूबर – 05 नवंब� ...

स्वास्थ्य प्रणाली पर बड़ा बोझ डाल रहा है तंबाकू – डॉक्टर – शालिनी सिंह

स्वास्थ्य प्रणाली पर बड़ा बोझ डाल रहा है तंबा ...

आई सी एम आर- एन आई सी पी आर में हिंदी दिवस एवं हिंदी पखवाडा समापन समारोह के अंतर्गत “ हिंदी हास्य काव्य पाठ प्रतियोगिता एवं पुरस्कार समारोह आयोजित किया गया

International yoga day – 21 june-2024, total figure tested for covid-19 by rt-pcr, total no of samples tested = 21,57,148*, home isolation & care for covid-19, covid-19 testing facility of nicpr.

Important Links

• Internships
• Career Advice
• Exam Alerts
• Scholarships
• Research Proposals ✍️
• Case Studies
• Promote & Earn
• Teach & Earn
• BioTecNika Global
• 💰 Earn from BioTecNika
• 👩‍🚀 Work @ BioTecNika
• 📜 Advertise With us
• 🤙 Contact Us
• 👬 About Us

From India with Precision: New CRISPR Enzyme Promises Better Genetic Editing

HIKE Announced under Various Career Fellowships of Department of Biotechnology

Postponement of the Joint CSIR-UGC-NET Examination June-2024

UGC’s BIG NEW UPDATE : Indian Universities Can Now Admit Students…

IISc Presents IMMUNOCON 2024 – The Conference Platform of the Indian…

Quality Assurance Intern Position at Rebel Foods – Apply Now!

Join CSMCRI as a Student Intern & Get Assistantship – MSc…

Unmissable Opportunity: Join NIPGR as a Student Trainee – Life Sciences…

Exclusive 2-Month Student Internship at NIPER! Apply Now!

Paid Student Internship at IARI – Apply Now!

Biotecnika Times Newsletter 31.07.2024 – Mega Walk-In-Drive at Reliance, Trainee Associate…

Biotecnika Times Newsletter 30.07.2024 – Quality Assurance Internship, TIGS Bioinformatics Research…

Biotecnika Times Newsletter 29.07.2024 – High-Pay Govt NIB & ICMR-NITVAR Jobs,…

Biotecnika Times Newsletter 26.07.2024 – Freshers Jobs at Syngene, CSIR NET…

Biotecnika Times Newsletter 25.07.2024 – 125+ Govt PGT Jobs With Rs….

CSIR NET LIFE Science & GATE Biotech Syllabus Comparison

Genetics career Scope and Opportunities

Will AI Take Our Jobs- Should Biotech Candidates Be Worried

JCB Scholarship Notification + CSIR NET Junoon Batch – Apply Now

Breaking News : CSIR NET 2022 Latest Exam Update With PROOF

Coding for Biologists For Beginners FREE eBook Download – Journey From…

CSIR NET UNIT 5 Developmental Biology Cheat Sheet FREE Download Available…

AI ML In Biology: A Complete Beginner’s Career Guide – Download…

CSIR NET 100 DAYS Master Study Planner For June 2024 …

CSIR NET Dec 2023 Cut Off Released For JRF / LS…

• BioTecNika TV

How To Become a Cancer Researcher in India – List of Cancer Research Institutes

Cancer Research in India – List of Cancer Research Institutes

Cancer – is a word that has devasted many lives. Many students ask Mr Shekhar Suman how they can make their careers in the field of cancer research? So in this video, we will show how you can become a cancer researcher in India or Abroad

Let’s get started

We will begin with Cancer Red Alert.

In 2018 there were around 10 million cases, which means more than a crore people were affected by this disease and by the time we reach 2030 – these numbers are going to touch 25 million. This means because of modern lifestyle and environmental conditions – it is going to double and triple.

CANCER RESEARCH SAVES LIVES

Cancer research is divided into 4 types

• Basic Research – Research at cellular, molecular & genetic levels
• Translational Research – Looks for solutions
• Clinical Research – Checking efficacy of drug molecules
• Population Research – Epidemiology of disease

Top 35 Cancer Research Labs & Institutes in India

• ACRC Trichur
• Asian Institute of Oncology, S.L.Raheja Hospital, Raheja Hospital Road, Mahim, Mumbai
• Bose Institute, Kolkata
• Cancer Institute (WIA), Chennai
• Cancer Treatment & Research Centre, Visakhapatnam
• Chittaranjan Cancer Institute, Kolkata
• Christian Cancer Centre, Andhra Pradesh
• Jaslok Hospital & Research Centre, Mumbai
• Dharamshila Cancer Hospital & Research Centre, Vasundhara Enclave, New Delhi
• Dr. B. Borooah Cancer Institute, Guwahati
• Dr. Bhubaneswar Borooah Cancer Institute, Guwahati
• Dr. Rai Memorial Cancer Institute 562, Chennai
• G.V.N. Cancer Centre, No.16, Kiledar Street, Tiruchirapalli, Tamil Nadu.
• Goa Cancer Society, GM Cancer Hospital & Research Institute, Goa.
• Indian Rly. Cancer Institute & Research Centre, Varanasi
• Institute of Cytology & Preventive Oncology, Opposite City Centre, Noida
• International Cancer Centre, Neyyoor, Tamilnadu
• International Network for Cancer, Treatment, & Research Rajinder Nagar, New Delhi
• J.K. Cancer Institute (G.S.V.M. Medical College), Kanpur, Uttar Pradesh.
• Jagdish Cancer & Research Centre, Hyderabad.
• Jawaharlal Nehru Cancer Hospital, & Research Centre, Bhopal
• Marathwada Cancer Hospital & Research Centre, Maharashtra.
• Bhagwan Mahaveer Cancer Hospital & Research Centre, Jaipur
• Mohan Das Oswal Cancer Treatment & Research Centre, Punjab.
• Rajiv Gandhi Cancer Hospital & Research Institute, Rohini, Delhi
• Rajkot Cancer Society, Mr. N.P. Cancer Institute, Gujrat
• Regional Cancer Centre, Thiruvananthapuram, Kerala.
• Regional Centre for Cancer Research, Adyar, Chennai.
• Regional Centre for Cancer Research and Treatment, Cuttack
• Rotary Cancer Centre, Kanpur, Uttar Pradesh
• Tata Memorial Centre, Mumbai
• The Gujarat Cancer & Research Institute, Ahmedabad

Status of Cancer research investment

If cancer is growing then so is the funding for research. So let’s talk about funding for this research

• Private companies
• Self-funded labs which run on donations

Now up until 2018 and 2022, the funding for cancer research was not as significant as it could be, but the discovery of an amazing tool called CRISPR has proven to be a game-changer.

CRISPR In Cancer Research

Why CRISPR for Cancer?

• Customizable

So does this interest you? Do you want to be at the helm of the new technology which is set to change the future of cancer research?

Learn the Nobel Prize-Winning Technique

Most in-Demand Skill for you

Enrol in CRISPR Cas9 Genome Editing – Virtual Internship

Career In Cancer Research

Once you have completed your UG and PG then you can look at a PhD either self-funded or financed and then progress onto a postdoc.

What are the Skills Required for a career in cancer research?

• Critical thinking
• Communication

Future Job Prospects – Be it government, pharma or biotech – all the industries will be looking at CRISPR experts.

RELATED ARTICLES MORE FROM AUTHOR

Work From Home Jobs in Bioinformatics- FREE eBook Download | How To Get Started & Earn From Home

Understanding the Challenges Faced By Biotech Freshers Looking For Job + Solutions

How to Freelance in Bioinformatics & Earn Big Online? Download Free Guide eBook

DBT-Research Associateship Programme in Biotech & Life Sciences 2024-2025 (Call-I)

Arturo falaschi short-term phd fellowships 2024 – apply online, hogeweg hesper bio-it scholarship launched – online application invited.

• Privacy Policy
• Terms of Service
• Advertise on BioTecNika

CHITTARANJAN NATIONAL CANCER INSTITUTE

MINISTRY OF HEALTH & FAMILY WELFARE

Department of health & family welfare.

Ministry of Health & Family Welfare Govt. of India Regional Cancer Center

Looking for the best cancer hospital in India? Our top-rated cancer Hospital Chittaranjan National Cancer Institute (CNCI) offers world-class treatment with cutting-edge technology and experienced oncologists.

Chittaranjan National Cancer Institute began its research efforts in 1957. At that time research activities at this institute had emphasized on the understanding of the biology of cancer particularly of the predominant types viz. oral cavity and uterine cervix. Today, Research at CNCI has reorganized in its infrastructure both for basic and clinical research to include need-based contemporary as well as futuristic research areas. The current approach is based on a programmed-oriented research in areas of identification of risk factors predominantly responsible for the development of cancer includes oral, breast, lung, ovary, colon etc. Scientists are devoting themselves to understand the molecular mechanism of development of these cancer types and target at different stages of the disease. The collaborative efforts between scientist & clinicians are generating the new era of preclinical model development as well as new clinical trial design which ultimately helping the cancer patients. Different arenas of investigations are going on to fight against cancer. A blend of basic as well as translational research is going on .

• Thursday 01 Aug, 2024
• English | हिंदी | বাংলা

Mrinal Kanti Ghosh

Chief Scientist & Head (CBID); Professor, AcSIR, New Delhi

[email protected]; [email protected]

Amit Kumar Srivastava

Senior Scientist

[email protected]

Amitava Sengupta

Senior Principal Scientist & Associate Professor, Biological Sciences, AcSIR

[email protected]

Debasis Nayak

[email protected]

Dipyaman Ganguly

Senior Principal Scientist & Professor (AcSIR)

[email protected],[email protected]

Shilpak Chatterjee

Principal Scientist & Assistant Professor (AcSIR), DBT-Wellcome Trust Intermediate Fellow

[email protected]; [email protected]

Siddik Sarkar

Senior Scientist, Asst. Professor (AcSIR)

[email protected]

LIST OF PUBLICATIONS OF THE DIVISION

--> --> -->   India Cancer Research Database (ICRD) provides details of scientists and physicians involved in cancer research in India along with information about their areas of expertise and research, publications and funded grants. The goal of the database is to foster collaborations among researchers and to provide a snapshot of the ongoing research initiatives and activities in India.   Researcher Profiles All researchers are strongly encouraged to update their individual profiles and research area according to relevance of the information maintained in the Cancer Researcher Database.                  User Name :     Password:     India Cancer Research Database has been developed by the with funding from the Department of Biotechnology, Government of India. We have 0 Cancer Biology PhD Projects, Programmes & Scholarships in India Biological Sciences Institution All Institutions All PhD Types All Funding There are no relevant disciplines based on your search. Cancer Biology PhD Projects, Programmes & Scholarships in India There are currently no PhDs listed for this Search. Why not try a new PhD search . FindAPhD. Copyright 2005-2024 All rights reserved. Unknown    ( change ) Have you got time to answer some quick questions about PhD study? Select your nearest city You haven’t completed your profile yet. To get the most out of FindAPhD, finish your profile and receive these benefits: Monthly chance to win one of ten £10 Amazon vouchers ; winners will be notified every month.* The latest PhD projects delivered straight to your inbox Access to our £6,000 scholarship competition Weekly newsletter with funding opportunities, research proposal tips and much more Early access to our physical and virtual postgraduate study fairs Or begin browsing FindAPhD.com or begin browsing FindAPhD.com *Offer only available for the duration of your active subscription, and subject to change. You MUST claim your prize within 72 hours, if not we will redraw. Do you want hassle-free information and advice? Create your FindAPhD account and sign up to our newsletter: Find out about funding opportunities and application tips Receive weekly advice, student stories and the latest PhD news Hear about our upcoming study fairs Save your favourite projects, track enquiries and get personalised subject updates Create your account Looking to list your PhD opportunities? Log in here . Filtering Results Director’s Message The Governing Body Scientific Advisory Board MSc Programme in Biotechnology & Bioinformatics MSc Programme in Big Data Biology PhD Programme Excellence in Research PhD Scholars RESEARCH TRAINING PROGRAMMES Post Doctoral Fellows Distinguished Professors and Chairs Faculty Members Scientific Professionals Adjunct Faculty Administrative Staff Students of MSc in Biotechnology and Bioinformatics Synthetic Biology Classrooms and Auditorium Facilitation Laboratories Housing and Dining Facilities Outreach Activities The Voice of IBABians Kiran Mazumdar-Shaw lecture series ACADEMICS AT IBAB Faculty members at IBAB pursue their independent research programs in frontier areas of Bioinformatics and Biotechnology, offering valuable opportunity for ambitious students to pursue a career in science through our PhD programme. The institute has state-of-the-art infrastructure, including high-end equipment and computing resources for the use by researchers. Doctoral students at IBAB get high quality research training which includes course work, conference presentations in India and possibly abroad, scientific writing and publishing. Candidates can register for a PhD with either Manipal Academy of Higher Education (MAHE) or The University of Trans-disciplinary Health Sciences and Technology (TDU). We welcome applications for the PhD programme from candidates who wish to join our research teams in the fields of Cancer Biology Computational Biology Epigenetics Infectious Disease Biology Mathematical Biology Microbiology Molecular Parasitology Structural Bioinformatics Structural Biology Systems Biology The research fellows have full access to high end research facilities, which include cell and molecular-biology equipment, culture facilities, fluorescence microscopes, FACS, HPLC/FPLC and 2D electrophoresis systems, DLS, DDPCRs, NGS sequencing facility comprising a HiSeq 2500 Sequencer, HiScan Beadchip Scanner and other accessories and equipment needed for high throughput sequencing. The institute has dedicated research laboratories, and an animal house needed for translational research. In addition our reserchers have access to other high-end instruments such as confocal microscope, mass spectrometer, LCMS, robotic liquid handling equipment and other specialized facilities available at BBC (Bangalore Bioinnovation Centre) next door, which is part of the Biotech Park. The institute is also equipped with high-end servers and high-performance computing clusters essential for research in big data and computational biology. UNIQUENESS OF THE PhD AT IBAB An opportunity to work in a truly multi-disciplinary environment, comprising mathematical biology, systems biology and experimental biology. Candidates must have at least 55% marks in their MSc or equivalent degree in science/engineering/medicine. Candidates with MBBS or BDS or any undergraduate degree which is of at least 5 years’ duration are also eligible to apply. Provisional admission is possible for candidates awaiting their final result. Admissions are announced once or twice a year depending on open positions. Look out for announcements on our website regularly. Short-listed candidates will have a telephone/skype interview during the preliminary screening. Selected candidates will be notified to attend an entrance exam and/or an in-person interview at IBAB. The candidate will be examined for basic scientific knowledge, research aptitude and communication skills. Shortlisted candidates with profiles matching the research interest of faculty members will be directed to the appropriate faculty. Admission to the PhD program will be based on mutual interest in a research area. Scholarships                       Candidates with their own fellowships are encouraged to apply, IBAB provides partial financial support to a limited number of candidates every year. Fees for the PhD course: Each PhD scholar has to pay the following fees: Research fee annually to IBAB, from the date of joining Coursework fees to IBAB, at the time of taking examinations. Fees specified by MAHE or TDU Syllabus                               All registered students need to undertake coursework worth 12 credits to continue their PhD registration. Doctoral Advisory Committee: A doctoral advisory committee (DAC) will be constituted for every candidate registered for a PhD. The DAC will evaluate the progress of the candidate every six months. CURRENT AND PAST PhD SCHOLARS Meet Mateusz Opyrchal, MD, PhD Feb 04, 2022 Mateusz Opyrchal Mateusz Opyrchal, M.D., Ph.D., began the New Year with a new job as the inaugural Vera Bradley Foundation Scholar in Breast Cancer Discovery in the Vera Bradley Foundation Center for Breast Cancer Research at the IU Simon Comprehensive Cancer Cente r. He also serves as the co-program leader of the cancer center’s Experimental and Development Therapeutics research program with Xiongbin Lu, Ph.D., and director of the solid tumor Phase I program. Dr. Opyrchal’s research focuses on novel therapeutic approaches and enhancing immune responses in triple negative breast cancer. His recruitment, made possible by Vera Bradley Foundation for Breast Cancer funding, expands IU’s leadership and knowledge base for the immunotherapy initiative with the goal of developing innovative approaches to help patients with this disease. Dr. Opyrchal answered questions about what brought him to IU, his research, and more. Q. What attracted you to IU? A. I was drawn by the opportunity to build a great program to move great science being done at IU into the clinic. Q. What can you tell us about your research? A. I’m interested in discovering new cancer targets with an emphasis on how they affect the tumor cells directly and the microenvironment surrounding them. Q. How do you see immunotherapy transforming the future of cancer treatment? A. We have all seen the impact immunotherapy has had already on the treatment of many cancers. Unfortunately, most patients with solid tumors, outside of a few outliers like melanoma, receive limited or no benefit from current immunotherapy treatments. I’m hopeful that we will be able to increase the number of patients benefiting from treatments and overcome some of the resistance pathways to increase duration of response. Q. What do you find most exciting about your cancer research? A. I think we all start out with the big dream of curing cancer. The many years of reality have shown us how difficult it is, but I’m hopeful that my research will bring us one small step closer. Q. What is the most rewarding part of being a physician? A. There are many, but if I was going to highlight a few: the relationships with patients where often you learn more from them about yourself and life in general as you guide them through the disease treatments; the relationship with your colleagues is also very rewarding and allows you to continually learn; and the relationship with the mentees and seeing them grow into their roles and become successful. Q. As you look back on your career, which cancer research advances most stand out to you? A. I started my fellowship just as ipilimumab (an immunotherapy medication) was approved and the changes over the last 10 years have been amazing to observe. Also, the concept of personalized medicine has developed and how to concentrate on one patient at a time with their unique features. Q. What are the biggest questions in cancer research that keep you up at night? A. I think we are all struggling with being better at preventing and curing metastatic disease without causing undue toxicities. Q. What do you like to do in your spare time? A. Trying to keep my two boys out of causing trouble seems to take up a lot of time. I find myself taking up taekwondo, golf and hiking in hopes of focusing their energies somewhere else–so far with not too much success outside of sore muscles for me. Suggested for you vadodara News No PhD registrations at MSU for past five months Visual Stories High school students get first-hand experience as cancer researchers at Winship Twelve high school students completed the 2024 Winship Summer Scholars Research Program. Twelve high school students gained first-hand experience in cancer research at Winship Cancer Institute of Emory University this summer. Their participation in Winship’s six-week Summer Scholars Research Program offered them the chance to conduct laboratory experiments and learn about diverse topics in clinical and basic science cancer research. Thirty additional students virtually attended the lecture series of the program. The program received an unprecedented number of applications in 2024, exceeding 250. The 2024 Winship Summer Scholars Research Program wrapped up on July 19 with a final symposium in which each student presented a research talk and scientific poster. This year’s symposium for the first time featured a keynote speaker, Mel Mann, a retired U.S. Army major and chronic myeloid leukemia survivor. He spoke about his experiences and the importance of clinical trials like the one for the drug Gleevec that saved his life over 25 years ago, highlighting the impact of cancer research on the lives of patients and their families. The program, which began in 2001, is currently co-directed by Winship members Cynthia Giver, PhD , and Nikolaos Papadantonakis, MD, PhD, MSc . Students selected for the program work with a Winship-affiliated research team and complete cancer-focused projects under the guidance and mentorship of a Winship principal investigator. In addition to working on their research projects, students take part in a variety of activities to enhance their scientific knowledge, learn about career paths and gain added exposure to the human side of cancer care. The 2024 curriculum included lab safety training; didactic lectures led by Winship faculty; panel discussions with cancer survivors, clinical fellows and previous summer scholars; field trips to the David J. Sencer CDC Museum, Emory Proton Therapy Center and Winship Cancer Institute at Emory Midtown; and presentation skill-building sessions in preparation for the final symposium. "Every year, I’m so impressed with our amazing students,” says Giver, associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. “They learn so much about the scientific area in their mentors’ labs and finish the six weeks by confidently presenting their research in a very professional way. It takes a special kind of student to dedicate six weeks of their summer to cancer research, and it’s our great privilege to work with them.” Giver adds, "We are grateful to our faculty mentors for providing outstanding research opportunities for the students and for guiding them through the projects." “We are thrilled with the number of highly talented students who applied to the program this year,” shares Papadantonakis, assistant professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. “We hope that the immersive research experience will further solidify the research interest of the scholars, and one day, these scholars will contribute to new advancements in cancer research.” Next year’s program dates and application details will be posted on the Summer Scholars Research Program web page in the fall. All eligible students interested in cancer research are encouraged to apply. Thanks to a generous gift from Lou Glenn, a long-time advocate for science education and cancer research, Winship now offers stipends to accepted students who complete the six-week program, making participation a viable option for interested students from a broader range of backgrounds than in previous years. Summer Scholars Program at Winship Appointments Our Providers For Physicians Making the leap from postdoc to principal investigator When Phoebe Hsieh, PhD, a postdoctoral research fellow at Fred Hutch Cancer Center, hits the job market later this year, she’ll bring more than her credentials and experience to the table. She’ll bring five years of funding from the Cystic Fibrosis Foundation to help become a principal investigator in charge of her own lab. Hsieh recently received the Postdoc-to-Faculty Transition Award from the Cystic Fibrosis Foundation. The award, which helps young scientists start an independent cystic fibrosis research program, includes $80,000 for salary support and $30,000 for research in the final two years. Hsieh will look for job possibilities at home in Taiwan as well as in the U.S. “I’m really grateful to have this funding,” Hsieh said. “If things work well, hopefully I will have my own lab by the summer of next year.” How a fight over magnesium undermines antibiotics Cystic fibrosis is a genetic disease that clogs the lungs, pancreas and other organs with thick mucus, making them more susceptible to multiple microbial infections. Hsieh received a Postdoctoral Research Fellowship Award from the Cystic Fibrosis Foundation in 2021 when she joined Fred Hutch. Hsieh’s research in Fred Hutch’s Malik Lab and the University of Washington’s Dandekar Lab focuses on how two microbial organisms — a fungus and a bacterium — compete for survival in the airways of people with cystic fibrosis. She helped forge a collaboration between the two labs, shepherding the project the way a principal investigator would. “In most respects, she has been the PI for the project, from conception to execution to publication,” said her mentor, Fred Hutch microbiologist and Howard Hughes Medical Institute Investigator Harmit Malik, PhD . Bacteria attack fungi in various ways, but Hsieh wanted to know more about how fungi keep bacteria in check. She is the lead author of a study published last month in PLOS Biology that identifies magnesium, an essential mineral for many cellular processes, as a key prize in the fungal-bacterial battle. She discovered that a fungus snarfs up magnesium, a mineral that a species of bacteria needs for maintaining strong cellular walls. In response, certain genetic mutations help the bacterium adapt to lower magnesium levels. But those adaptations also make the bacterium less vulnerable to an antibiotic that destroys the bacterium’s cell walls by displacing magnesium. Antibiotic resistance typically develops when bacteria survive exposure to an antibiotic and pass on the genes that helped it escape to new generations. Hsieh discovered that the resistance is a temporary condition resulting from the fight with fungi over magnesium. The resistance can be reversed by either adding magnesium so there’s enough to go around or by removing the fungus. “This opens a new window for us to understand what those new mutations actually do and why they are so distinct from the canonical mutations we know cause antibiotic resistance,” Hsieh said. A lab of her own The path from postdoc to principal investigator has grown narrower and more competitive in recent years. In the early 1960s, about 60 percent of life science PhDs achieved tenure within 10 years of graduation. But by 2021, only 3.5 percent of biology PhD students working at universities reached that goal, according to a National Science Foundation survey cited in a 2023 Stat News report . Postdoctoral researchers hired at Fred Hutch typically spend a few years obtaining additional experience after earning their PhDs before venturing out into the job market. They are essential to the research mission and Fred Hutch competes with other institutions to hire the best. The Basic Sciences Division will host a three-day symposium in September for prospective postdocs to learn more about opportunities at Fred Hutch. Of the 68 postdocs who left Fred Hutch in 2022 to launch their careers in science, 62 percent moved on to research jobs in academia, for-profit companies, nonprofit organizations and government. Just 15 percent of Fred Hutch postdocs in 2022 were hired in tenure-track academic positions – the traditional route to becoming a principal investigator in charge of a lab. The Cystic Fibrosis Foundation award makes that journey easier. “Launching thriving independent research labs in academia has become a more and more daunting prospect,” Malik said. “Not only is the project a validation of the foundation 's hope and confidence in the merit of Phoebe's research program, but the financial boost that this award provides will enable her to be bolder in launching her independent research program and recruiting equally bold members to her future lab.” John Higgins John Higgins, a staff writer at Fred Hutch Cancer Center, was an education reporter at The Seattle Times and the Akron Beacon Journal. He was a Knight Science Journalism Fellow at MIT, where he studied the emerging science of teaching. Reach him at [email protected] . reprint-republish Are you interested in reprinting or republishing this story? Be our guest! We want to help connect people with the information they need. We just ask that you link back to the original article, preserve the author’s byline and refrain from making edits that alter the original context. Questions? Email us at [email protected] Are you interested in reprinting or republishing this story? Be our guest! We want to help connect people with the information they need. We just ask that you link back to the original article, preserve the author’s byline and refrain from making edits that alter the original context. Questions? Email us at  [email protected] Related News Help us eliminate cancer. Every dollar counts. Please support lifesaving research today. Basic Sciences Basic Sciences Division Harmit Malik Patients & Families Donors & Volunteers Science Professionals Medical Professionals Job Seekers Educators & Students Scientific Seminars For the Media Contact Media Relations News Releases Media Coverage About Fred Hutch Fred Hutchinson Cancer Center An official website of the United States government The .gov means it’s official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. Publications Account settings My Bibliography Collections Citation manager Save citation to file Email citation, add to collections. Create a new collection Add to an existing collection Add to My Bibliography Your saved search, create a file for external citation management software, your rss feed. Search in PubMed Search in NLM Catalog Add to Search A comprehensive overview of radiation therapy impacts of various cancer treatments and pivotal role in the immune system Affiliations. 1 Centre for Advanced Biotherapeutics and Regenerative Medicine, Faculty of Research, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, India. 2 Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York, USA. 3 Department of Pharmacology, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, India. 4 Department of Basic Medical and Dental Sciences, College of Dentistry, Gulf Medical University, Ajman, United Arab Emirates. 5 Centre for Herbal Pharmacology and Environmental Sustainability, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, India. 6 Department of Allied Health Sciences-FAHS, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, India. PMID: 39073207 DOI: 10.1002/cbf.4103 The cancer treatment landscape is significantly evolving, focusing on advanced radiation therapy methods to maximize effectiveness and minimize the adverse effects. Recognized as a pivotal component in cancer and disease treatment, radiation therapy (RT) has drawn attention in recent research that delves into its intricate interplay with inflammation and the immune response. This exploration unveils the underlying processes that significantly influence treatment outcomes. In this context, the potential advantages of combining bronchoscopy with RT across diverse clinical scenarios, alongside the targeted impact of brachytherapy, are explored. Concurrently, radiation treatments serve multifaceted roles such as DNA repair, cell elimination, and generating immune stress signaling molecules known as damage-associated molecular patterns, elucidating their effectiveness in treating various diseases. External beam RT introduces versatility by utilizing particles such as photons, electrons, protons, or carbon ions, each offering distinct advantages. Advanced RT techniques contribute to the evolving landscape, with emerging technologies like FLASH, spatially fractionated RT, and others poised to revolutionize the field. The comprehension of RT, striving for improved treatment outcomes, reduced side effects, and facilitating personalized and innovative treatments for cancer and noncancer patients. After navigating these advancements, the goal is fixed to usher in a new era in which RT is a cornerstone of precision and effectiveness in medical interventions. In summarizing the myriad findings, the review underscores the significance of understanding the differential impacts of radiation approaches on inflammation and immune modulation, offering valuable insights for developing innovative therapeutic interventions that harness the immune system in conjunction with RT. Keywords: advanced radiation therapy; damage‐associated molecular pattern; immune modulation; immune response; inflammation. © 2024 John Wiley & Sons Ltd. PubMed Disclaimer Baskar R, Lee KA, Yeo R, Yeoh K‐W. Cancer and radiation therapy: current advances and future directions. Int J Med Sci. 2012;9(3):193‐199. Apisarnthanarax S, Barry A, Cao M, et al. External beam radiation therapy for primary liver cancers: an ASTRO clinical practice guideline. Pract Radiat Oncol. 2022;12(1):28‐51. Monjazeb AM, Schalper KA, Villarroel‐Espindola F, Nguyen A, Shiao SL, Young K. Effects of radiation on the tumor microenvironment. Semin Radiat Oncol. 2020;30:145‐157. Vaes RDW, Hendriks LEL, Vooijs M, De Ruysscher D. Biomarkers of radiotherapy‐induced immunogenic cell death. Cells. 2021;10(4):930. Koukourakis MI, Giatromanolaki A. Lymphopenia and intratumoral lymphocytic balance in the era of cancer immuno‐radiotherapy. Crit Rev Oncol Hematol. 2021;159:103226. Publication types Search in MeSH Related information Linkout - more resources, full text sources. MedlinePlus Health Information Citation Manager NCBI Literature Resources MeSH PMC Bookshelf Disclaimer The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited. 297 IMAGES Complete List Of Cancer Research Institutes In India North India's Leading Cancer Research Institute The Role of Cancer Research Sites in India in advancing cancer care and How To Become a Cancer Researcher in India Harnessing genomics to improve outcomes for women with cancer in India Indian-Origin Cancer Researchers Honored at the 30th Annual Meeting of VIDEO Pros & cons of Pathology as a career option in India PhD in India vs PhD Abroad Pathophysiology IARC Award for Women in Cancer Research The science behind cancer Medical student does a PhD // Intro COMMENTS India's best Oncology and Cancer research universities [Rankings] Bharath Institute of Higher Education and Research. 99. K L University. 100. Indian Institute of Technology Indore. The best cities to study Oncology and Cancer research in India based on the number of universities and their ranks are Delhi, Chandigarh, Varanasi, and Lucknow. Best Ph.D Oncology Colleges in India Check out list of top Ph.D in Oncology colleges in India with courses, fees, cut-off, admission, placement, reviews, ranking, latest news, and more on careers360.com. Browse by Stream. ... Rajiv Gandhi Cancer Institute and Research Centre, Delhi. Delhi, Delhi. 5.0/5 1 Reviews. Public/Govt. Cancer Research Cancer Research is RGCB's leading flagship programme led by a network of 15 investigators understanding the fundamental mechanisms of cancer biology with the eventual goal of harnessing the potential that emerges from increasing knowledge to develop effective management strategies for cancer. Santhosh Kumar T . R, PhD. S Asha Nair, PhD. The Gujarat Cancer & Research Institute Contact Details. Department of Cancer Biology (Research) Direct : 079-22688000 ; 079-22690000. Cancer Biology Department was established in 1980 with primary research focus area on Cell Biology, Molecular Endocrinology and Biochemistry which has now metamorphosed into 6 state of the art research laboratories as under: Immunohematology Lab. Mazumdar-Shaw International Post Doctoral Oncology ... Attn: Mazumdar-Shaw Fellowship. 77 Massachusetts Avenue, Building 76-158. Cambridge, MA 02139. United States of America. E [email protected] o. MIT has established the Mazumdar-Shaw International Oncology Fellows Program: a high-impact, bilateral collaboration with India focusing on cancer research training as its cornerstone. The aim of ... C. K. Handoo Scholarship Indian Cancer Society &-C. K. Handoo Scholarship for Research in Cancer. ICS relaunched the CK Handoo Scholarship on World Cancer Day in February 2023 by broadening the scope and criteria. The corpus represents a donation by Mrs. Manorajana Kaul in 1969 in memory of her late mother Mrs. Chandra Kumari Handoo; the interest derived out of the corpus is used for the grant to grant fellowship ... Integrated Ph. D. Programmes The Institute offers exciting opportunities to motivated and talented Bachelor's degree holders with a keen sense of scientific enquiry for pursuing advanced research in frontier areas of Biological, Chemical, Physical and Mathematical Sciences leading to a Ph D degree. Experience shows that students entering this program save nearly a year ... PhD Cancer Biology Download Brochure. PhD Cancer Biology at Shoolini University focuses on hi-impact cutting-edge research and learning to provide solutions to one of the biggest health concerns for humankind. This interdisciplinary program opens new avenues for students as per the rising demand of trained Cancer Biologists in the academic and corporate world. Breast Cancer and Stem Cells The primary focus of Dr. Rangarajan's laboratory is to understand the origin and biology of CSCs, and to develop strategies to target them towards more effective cancer treatment. The "stem cell theory" of cancer predicts that cancers originate in the normal, adult stem cells. To test this, Dr. Rangarajan's group introduced various ... Cancer Immunology and Immunotherapy PhD Program The PhD Program in Cancer Immunology and Immunotherapy at Moffitt provides an enriched educational environment by blending advanced studies in fundamental cancer immunology and novel immunotherapies. The program fosters interdisciplinary research through collaborations with experts in immunology, oncology, molecular biology, metabolism ... Cancer research in India: national priorities, global results Over the past 20 years, cancer research in India has grown in size and impact. Clinicians, scientists, and government and state policy makers in India have championed cancer research, from studies to achieve low-tech, large-scale health outcomes to some of the most advanced areas of fundamental cancer science. In this paper, we frame public policy discussions about cancer with use of an in ... TRAINING PROGRAMMES Applications invited for PhD programme in Medical Research affiliated to AcSIR. Last date: April 30, 2024. ... ICMR-National Institute of Cancer Prevention and Research, Ministry of Health and Family Welfare, Government of India ... Gautam Buddha Nagar, U.P - 201301, INDIA +91 - 120 - 2446938, PABX: 2446900, Fax: +91 - 120 - 2579473 ... Cancer research in India: Challenges & opportunities The National Cancer Registry Programme was commenced by the ICMR in December 1981 and is a major source of information on cancer incidence and pattern in the country. Currently, there are 29 population-based cancer registries (PBCRs) and 29 hospital-based cancer registries. These cover about 10 per cent of India's population. ICMR ICMR-National Institute of Cancer Prevention and Research, Ministry of Health and Family Welfare, Government of India Address I - 7, Sector - 39, NOIDA, Distt. Gautam Buddha Nagar, U.P - 201301, INDIA +91 - 120 - 2446938, PABX: 2446900, Fax: +91 - 120 - 2579473 Cancer Research in India Cancer research is divided into 4 types. Top 35 Cancer Research Labs & Institutes in India. G.V.N. Cancer Centre, No.16, Kiledar Street, Tiruchirapalli, Tamil Nadu. Goa Cancer Society, GM Cancer Hospital & Research Institute, Goa. Indian Rly. Cancer Institute & Research Centre, Varanasi. Research Chittaranjan National Cancer Institute began its research efforts in 1957. At that time research activities at this institute had emphasized on the understanding of the biology of cancer particularly of the predominant types viz. oral cavity and uterine cervix. Today, Research at CNCI has reorganized in its infrastructure both for basic and ... Cancer Biology & Inflammatory Disorder The faculties conduct both basic and translational research on a range of topics that include lung, brain, oral, breast, pancreatic and cervical cancers and leukemias etc. Our current focus is on identification of pure herbal and/or synthetic compounds/herbal extracts having in-vitro anti-proliferative activities against different cancer cell ... India Cancer Research Database India Cancer Research Database (ICRD) provides details of scientists and physicians involved in cancer research in India along with information about their areas of expertise and research, publications and funded grants. The goal of the database is to foster collaborations among researchers and to provide a snapshot of the ongoing research ... CCMB PhD Program. Please note that the last date for application for CSIR-CCMB is March 31, 2024. Those with a strong motivation to pursue research in modern biology are encouraged to apply for entry into our PhD program. CSIR-CCMB August 2024 PhD Programme. CCMB Aug-2024 PhD Program - List of Selected Candidates , 684 KB , Fellowship Programs List of candidates for selected for Fellowship Programme in Onc. Contact Details : Ms. Neelima Chhibber, Academic Assistant, #01147022622, 8860415998. Rajiv Gandhi Cancer Institute and Research Centre is today counted amongst Asia's premier exclusive cancer centres that offer unique advantage of cutting edge technology, put to use by renowned ... Iacr Dear Colleagues, Cancer Research is thriving in India, which is reflected in how IACR membership has expanded over the last few years. Cancer Research in India encompasses basic research in cancer biology, and in recent years, this has been accompanied by wonderful advances in bringing both new diagnostic and prognostic measures to the clinic and new therapeutic practices to improve patient care. Cancer Biology PhD Projects, Programmes & Scholarships in India The latest PhD projects delivered straight to your inbox; Access to our £6,000 scholarship competition; Weekly newsletter with funding opportunities, research proposal tips and much more; Early access to our physical and virtual postgraduate study fairs; Complete your profile. or begin browsing FindAPhD.com PhD Programme PhD Programme. Faculty members at IBAB pursue their independent research programs in frontier areas of Bioinformatics and Biotechnology, offering valuable opportunity for ambitious students to pursue a career in science through our PhD programme. The institute has state-of-the-art infrastructure, including high-end equipment and computing ... Q&A with Michele Coté, PhD Michele Coté, Ph.D., is just getting started in her new role as the second director of the Susan G. Komen Tissue Bank at IU Simon Comprehensive Cancer Center.. An internationally recognized molecular cancer epidemiologist and health disparities researcher, she began at IU on Sept. 1.. In addition to her role with the Komen Tissue Bank, Coté is the inaugural Dr. Carrie Ann Glasscock West ... PhD student in Cancer Research The PhD student will work on a Télévie-funded project that aims to identify which cells are targeted by sEV in CLL and its microenvironment, and to determine the effects of sEV on metabolism. Meet Mateusz Opyrchal, MD, PhD Contact Indiana University School of Medicine. 340 West 10th Street Fairbanks Hall, Suite 6200 Indianapolis, IN 46202-3082 317-274-8157; [email protected] No PhD registrations at MSU for past five months Vadodara: Research, an important component of any higher education institute, has come to a standstill at M S University as no scholar has been registered for a PhD degree for the past five months High school students get first-hand experience as cancer researchers at The program, which began in 2001, is currently co-directed by Winship members Cynthia Giver, PhD, and Nikolaos Papadantonakis, MD, PhD, MSc. Students selected for the program work with a Winship-affiliated research team and complete cancer-focused projects under the guidance and mentorship of a Winship principal investigator. Making the leap from postdoc to principal investigator When Phoebe Hsieh, PhD, a postdoctoral research fellow at Fred Hutch Cancer Center, hits the job market later this year, she'll bring more than her credentials and experience to the table. She'll bring five years of funding from the Cystic Fibrosis Foundation to help become a principal investigator in charge of her own lab. A comprehensive overview of radiation therapy impacts of various cancer The cancer treatment landscape is significantly evolving, focusing on advanced radiation therapy methods to maximize effectiveness and minimize the adverse effects. ... Chettinad Academy of Research and Education, Kelambakkam, India. 4 Department of Basic Medical and Dental Sciences, College of Dentistry, Gulf Medical University, Ajman, United ... assignment essay homework paper phd report resume review speech thesis